Michelle Dawson posts

Post published on Bluesky on 2 Jun 2026 11:34

Bluesky DOI work crossref Extract quoted in the post Question asked by Dawson in the post External link integrated into the post Autism terms

"Irritability in autistic adults is a major crisis"? "what is labeled 'irritability' in many autistic adults may often be a physiological response to cumulative stress or trauma, or a manifestation of intrinsic neurobiological dysregulation..."? onlinelibrary.wiley.com/doi/10.1002/... review, free

View on Bluesky

Structured cited links

1 cited resource

DOI work Fetched Post crossref

Hsiang‐Yuan Lin, Arthur N. Westover, Amy S. F. Lutz, Manish K. Jha (2026). Beyond the Outburst: Charting a New Frontier for Understanding and Treating Irritability in Autistic Adults. Autism Research, e70287. Wiley.

Publication date
1 Jun 2026
Identifier
10.1002/aur.70287
Authors
Hsiang‐Yuan Lin, Arthur N. Westover, Amy S. F. Lutz, Manish K. Jha
Source
Autism Research
Details
e70287
Reference type
article
Publisher
Wiley
Metadata source
crossref

Abstract

ABSTRACT Irritability is a prevalent and impairing feature associated with autism, yet remains poorly understood, particularly in adults. Drawing heavily on insights translated from pediatric and transdiagnostic literatures, we propose that irritability in autistic individuals often reflects a psychophysiological stress or threat response, rooted in a vulnerable neurobiology (e.g., sensory sensitivities, intolerance of uncertainty), but may also stem from intrinsic neurobiological dysregulation independent of environmental triggers. The current treatment paradigm for autistic adults, largely extrapolated from pediatric antipsychotic trials, leaves these adults critically underserved due to a lack of evidence‐based treatments, clinical trials, or validated tools to measure their internal experience. This viewpoint deconstructs irritability, differentiating its affective nature from aggression, and highlights heterogeneity across the lifespan and support needs. We critique the limitations of current assessment methods and recommend a shift toward a multi‐modal strategy integrating self‐report (when feasible) with objective, physiologically‐informed tools (e.g., wearable biosensors) and nuanced observer reports. We argue that the field is poised for neuroscience‐informed treatment innovation—including novel pharmacological agents and adapted psychosocial interventions—but is hampered by a lack of rigorous clinical trials in adults. Finally, we call for mechanistically driven trials to address the large unmet burden of inadequately treated irritability, ultimately improving the quality of life for autistic adults and their families/caregivers.

Study authors in this cited reference